Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Assam El-Osta

Showing results (81-90 of 225) with videos related to

Pageof 23
Sort By:
Biochimie|June 19, 2012
A pipeline for the identification and characterization of chromatin modifications derived from ChIP-Seq datasetsAntony Kaspi, Mark Ziemann, Haloom Rafehi, et al.
Molecular and Cellular Biology|February 28, 2002
Precipitous release of methyl-CpG binding protein 2 and histone deacetylase 1 from the methylated human multidrug resistance gene (MDR1) on activationAssam El-Osta, Phillip Kantharidis, John R Zalcberg, et al.
Neuroscience and Biobehavioral Reviews|June 28, 2016
Epigenomic changes associated with impaired norepinephrine transporter function in postural tachycardia syndromeAbdul Waheed Khan, Susan J Corcoran, Murray Esler, et al.
Epigenetics|November 20, 2013
Interplay of chromatin modifications and non-coding RNAs in the heartPrabhu Mathiyalagan, Samuel T Keating, Xiao-Jun Du, et al.
RNA Biology|November 26, 2013
Chromatin context and ncRNA highlight targets of MeCP2 in brainScott S Maxwell, Gregory J Pelka, Patrick Pl Tam, et al.
Journal of Structural Biology|June 25, 2025
Insights into the pathogenic mechanisms associated with the SARS-CoV-2 spike proteinMia Argyrou, Eleni Pitsillou, Andrew Hung, et al.
Cell Cycle (Georgetown, Tex.)|February 2, 2008
Effect of valproic acid on radiation-induced DNA damage in euchromatic and heterochromatic compartmentsK N Harikrishnan, Tom C Karagiannis, Maggie Z Chow, et al.
Oncogene|August 11, 2005
Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugsEmma K Baker, Ricky W Johnstone, John R Zalcberg, et al.
Frontiers in Genetics|January 30, 2023
Editorial: RNA-chromatin interactions: Biology, mechanism, disease and therapeuticsPrabhu Mathiyalagan, Luciano G Martelotto, Samir Ounzain, et al.
Biochemical Pharmacology|September 24, 2016
Pharmacological inhibition of arginine and lysine methyltransferases induces nuclear abnormalities and suppresses angiogenesis in human endothelial cellsAneta Balcerczyk, Dorota Rybaczek, Martyna Wojtala, et al.
Pageof 23

Showing results (81-90 of 225) with videos related to

Sort By:
Pageof 23
Biochimie|June 19, 2012
A pipeline for the identification and characterization of chromatin modifications derived from ChIP-Seq datasetsAntony Kaspi, Mark Ziemann, Haloom Rafehi, et al.
Molecular and Cellular Biology|February 28, 2002
Precipitous release of methyl-CpG binding protein 2 and histone deacetylase 1 from the methylated human multidrug resistance gene (MDR1) on activationAssam El-Osta, Phillip Kantharidis, John R Zalcberg, et al.
Neuroscience and Biobehavioral Reviews|June 28, 2016
Epigenomic changes associated with impaired norepinephrine transporter function in postural tachycardia syndromeAbdul Waheed Khan, Susan J Corcoran, Murray Esler, et al.
Epigenetics|November 20, 2013
Interplay of chromatin modifications and non-coding RNAs in the heartPrabhu Mathiyalagan, Samuel T Keating, Xiao-Jun Du, et al.
RNA Biology|November 26, 2013
Chromatin context and ncRNA highlight targets of MeCP2 in brainScott S Maxwell, Gregory J Pelka, Patrick Pl Tam, et al.
Journal of Structural Biology|June 25, 2025
Insights into the pathogenic mechanisms associated with the SARS-CoV-2 spike proteinMia Argyrou, Eleni Pitsillou, Andrew Hung, et al.
Cell Cycle (Georgetown, Tex.)|February 2, 2008
Effect of valproic acid on radiation-induced DNA damage in euchromatic and heterochromatic compartmentsK N Harikrishnan, Tom C Karagiannis, Maggie Z Chow, et al.
Oncogene|August 11, 2005
Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugsEmma K Baker, Ricky W Johnstone, John R Zalcberg, et al.
Frontiers in Genetics|January 30, 2023
Editorial: RNA-chromatin interactions: Biology, mechanism, disease and therapeuticsPrabhu Mathiyalagan, Luciano G Martelotto, Samir Ounzain, et al.
Biochemical Pharmacology|September 24, 2016
Pharmacological inhibition of arginine and lysine methyltransferases induces nuclear abnormalities and suppresses angiogenesis in human endothelial cellsAneta Balcerczyk, Dorota Rybaczek, Martyna Wojtala, et al.
Pageof 23